The FDA approved Nov. 8 Celegene's drug, Reblozyl, designed to treat anemia in adult patients with beta thalassemia who require regular red blood cell transfusions.
Pharmacy
A federal jury in Seattle awarded a former Biogen sales representative nearly $6 million after she claimed the drugmaker fired her for refusing to pursue off-label marketing, according to STAT.
Aurobindo Pharma joined a growing list of drugmakers recalling their ranitidine products over concerns they produce a possible carcinogen.
A former Sun Pharmaceuticals national account director filed a retaliation lawsuit against the drugmaker, claiming she was fired for objecting to off-label marketing.
The House will not vote on House Speaker Nancy Pelosi's drug pricing bill until at least December, a senior Democratic aide told Politico.
Advertisement
Endo International is searching for a new CEO after Paul Campanelli said this week that he intends to retire, according to the Philadelphia Business Journal.
Below are 16 legal actions involving members of the drug supply chain, including pharmaceutical manufacturers, pharmacies, pharmacists, patient charities, distributors and executives, reported by Becker's Hospital Review in the last two months:
Walgreens handled about 20 percent of oxycodone and hydrocodone pills in U.S. pharmacies during the height of the opioid crisis, according to The Washington Post.
The Trump administration filed a lawsuit against Gilead Nov. 6, accusing the drugmaker of making billions of dollars from taxpayer-funded research without paying taxpayers back.
HealthPartners, a nonprofit healthcare provider and insurer in Bloomington, Minn., will close all of its retail pharmacies and shut down its mail-order pharmacy operations next year, according to the Pioneer Press.